These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26248221)

  • 1. In silico research to assist the investigation of carboxamide derivatives as potent TRPV1 antagonists.
    Wang J; Li Y; Yang Y; Du J; Zhang S; Yang L
    Mol Biosyst; 2015 Nov; 11(11):2885-99. PubMed ID: 26248221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.
    Feng Z; Pearce LV; Xu X; Yang X; Yang P; Blumberg PM; Xie XQ
    J Chem Inf Model; 2015 Mar; 55(3):572-88. PubMed ID: 25642729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR analysis of TRPV1 inhibitors reveals a pharmacophore applicable to diverse scaffolds and clinical candidates.
    Kristam R; Parmar V; Viswanadhan VN
    J Mol Graph Model; 2013 Sep; 45():157-72. PubMed ID: 24036505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT
    Lin F; Li F; Wang C; Wang J; Yang Y; Yang L; Li Y
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28672848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
    Yan Y; Li Y; Zhang S; Ai C
    J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
    Khan N; Halim SA; Khan W; Zafar SK; Ul-Haq Z
    J Mol Graph Model; 2019 Jun; 89():199-214. PubMed ID: 30908997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Structural Requirements of N-Substituted Tetrahydro-β-Carboline Imidazolium Salt Derivatives Using in Silico Approaches for Designing MEK-1 Inhibitors.
    Liang J; Wang M; Li X; He X; Cao C; Meng F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.
    Yang Y; Li Y; Pan Y; Wang J; Lin F; Wang C; Zhang S; Yang L
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26797608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the structure determinants of pyrazinone derivatives as PDE5 3HC8 inhibitors: an in silico analysis.
    Li Y; Wu W; Ren H; Wang J; Zhang S; Li G; Yang L
    J Mol Graph Model; 2012 Sep; 38():112-22. PubMed ID: 23085160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the structural determinants of imidazole scaffold-based derivatives as p38 MAP kinase inhibitors by computational explorations.
    Huang C; Li Y; Ren H; Wang J; Shao L; Zhang S; Li G; Yang L
    Curr Med Chem; 2012; 19(23):4024-37. PubMed ID: 22680637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico profiling the interaction mechanism of 2,5-diketopiperazine derivatives as oxytocin antagonists.
    Yang M; Luo J; Zeng Z; Yang L; Xu L; Li Y
    J Mol Graph Model; 2019 Jun; 89():178-191. PubMed ID: 30904734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y; Gao W; Li F; Wang J; Zhang J; Yang Y; Zhang S; Yang L
    Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of 2-Nitroimidazooxazine Derivatives as Deazaflavin-Dependent Nitroreductase (Ddn) Activators as Anti-Mycobacterial Agents Based on 3D QSAR, HQSAR, and Docking Study with In Silico Prediction of Activity and Toxicity.
    Gupta N; Vyas VK; Patel BD; Ghate M
    Interdiscip Sci; 2019 Jun; 11(2):191-205. PubMed ID: 28895050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of imidacloprid-based nicotinic acetylcholine receptor inhibitors identified using 3D-QSAR, docking and molecular dynamics.
    Li Q; Kong X; Xiao Z; Zhang L; Wang F; Zhang H; Li Y; Wang Y
    J Mol Model; 2012 Jun; 18(6):2279-89. PubMed ID: 22116611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Modeling to Explain Why 5,5-Diarylpentadienamides are TRPV1 Antagonists.
    Caballero J
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.